Regulatory Compliance

Cibola County Commissioners Back Uranium ISR Mining in Grants Mineral Belt

Grants, New Mexico – October 07, 2026 -- The Cibola County Board of Commissioners has passed a resolution recognizing the strategic importance of the Grants Mineral Belt and In-Situ Recovery (ISR) technology for uranium extraction, the Clean Energy Association of New Mexico (CLEAN) announced.

Cibola County formally endorses ISR as a path for uranium development

The county resolution acknowledges ISR's potential to extract naturally occurring uranium without generating tailings or requiring underground workings, according to CLEAN. CLEAN President Janet Lee-Sheriff said the vote reflects research by county officials and staff aimed at making an informed decision based on sound information.

Enliven Secures FDA Alignment on Phase 3 CML Trial Design

Burlingame, Calif. – October 07, 2026 -- Enliven Therapeutics, Inc. (Nasdaq: ELVN) has reached alignment with the U.S. Food and Drug Administration on the final design of ENABLE-2, a pivotal Phase 3 trial testing relcobatinib against standard second-generation therapies in previously treated chronic myeloid leukemia (CML). The company remains on track to initiate the trial before year-end 2026.

FDA clears path for 450-patient head-to-head comparison

ENABLE-2 is designed to enroll approximately 450 adults with CML who have already received one or more tyrosine kinase inhibitors (TKIs). Participants will be randomized 1:1 to receive either relcobatinib at 80 mg once daily or an investigator-selected second-generation TKI -- dasatinib, nilotinib, or bosutinib. The primary endpoint is major molecular response (MMR) at Week 24, with MMR at Week 96 as a key secondary measure.

Experts: Drainage Planning Cuts Flood, Foundation Risk Pre-Construction

Pueblo, Colo. – October 07, 2026 -- Unmanaged runoff during site preparation can trigger erosion, foundation damage, and site-access failures during storms, according to an analysis published by HelloNation featuring engineering and surveying expert Michael Cuppy of Pueblo, Colorado.

Drainage mapping identifies low points before grading begins

The analysis describes drainage planning as a process that maps natural runoff flow and low points across a building site before grading decisions are finalized. Engineers use this data to design swales, retention areas, and underground piping systems that direct water away from structures, roads, and utilities. Builders who skip this step risk standing water, soil instability, and basement flooding that can extend liability to neighboring properties.

CMS Grants NTAP Reimbursement for icotec's CMORE CT Spine Implant

Altstätten, Switzerland and Boston – October 07, 2026 -- The Centers for Medicare & Medicaid Services has approved a New Technology Add-On Payment for icotec's CMORE® CT spine implant system, effective October 07, 2026, opening expanded reimbursement access for eligible hospitals treating Medicare patients.

CMS reimbursement decision follows April 2025 Break-Through Device Designation

icotec's CMORE® Cervicothoracic System received FDA Break-Through Device Designation in April 2025, a status that preceded the latest NTAP approval. The NTAP program provides eligible hospitals additional payment for qualifying technologies used in traditional Medicare procedures, applying here to specified spinal conditions and surgeries.

DCA Manufacturing Secures AS9100D Certification at Two US Plants

Troy, Michigan – October 07, 2026 -- DCA Manufacturing has achieved AS9100D certification at its Troy, Michigan and Cumberland, Wisconsin facilities, the aerospace industry's internationally recognized quality management standard for aviation, space and defense suppliers.

Certification covers PCBA production and complex system integration at both plants

The AS9100D certification applies to the manufacturing, servicing and testing of electronic Printed Circuit Board Assemblies (PCBAs) and complex system integrations across DCA's two US manufacturing sites. The standard incorporates aerospace-specific requirements covering operational risk, configuration management, product safety, supplier quality, traceability and counterfeit parts prevention.

Reliever Launches AI Back-Office Platform for Youth Sports Finances

Minneapolis – October 07, 2026 -- Reliever, a new fintech platform, launched to automate the banking, bookkeeping and compliance work that volunteer treasurers at youth sports associations have historically managed by hand. The company targets a segment of youth sports where billions of dollars flow annually through what it describes as fragmented, fragile financial infrastructure never designed for that scale of money.

Platform consolidates banking, budgeting and compliance into one system

Reliever provides an insured operating account along with virtual and physical cards for each team, governed by built-in spend policies. The platform lets boards build annual budgets, track actuals in real time, and generate board-ready financial statements readable by non-finance volunteers. Vendor payments, W-9s and 1099s are processed within the same system, giving boards a single view of every account and transaction.

NCCN Summit: Screening Could Cut Cancer Deaths Nearly 50%

Washington, D.C. – October 07, 2026 -- Established cancer prevention and screening strategies have the power to eliminate nearly half of all cancer deaths, yet fragmented delivery systems risk deepening existing disparities, according to policy experts convened at the National Comprehensive Cancer Network (NCCN) Oncology Policy Summit held October 5-6, 2026, at the National Press Club in Washington, D.C.

NCI and CDC leaders join policymakers to address screening access gaps

The two-day summit featured keynote presentations from Anthony Letai, MD, PhD, Director of the National Cancer Institute, and Captain Jacqueline Miller, MD, Acting Division Director of the CDC Division of Cancer Prevention and Control. Panels brought together patients, providers, payers, and advocacy groups including LUNGevity Foundation, Susan G. Komen, FORCE, and the LGBTQIA+ Cancer Network to examine policy solutions at both population and individual levels.

Comtrend Wins FCC Nod for Wi-Fi 6 VDSL Gateway as DSL Vendors Dwindle

Irvine, Calif. – October 06, 2026 -- Comtrend has secured FCC conditional approval for its PBL-6201 Wi-Fi 6 Bonded VDSL Gateway, giving broadband service providers a certified equipment option as fewer vendors continue manufacturing DSL gear.

Rural Providers Still Rely Heavily on Copper Networks

According to NTCA's 2025 Broadband/Internet Availability Survey, 40.8% of surveyed rural broadband providers still serve some customers over copper lines. With equipment vendors increasingly exiting the DSL gateway market, replacement and upgrade options for these providers have narrowed.

C5 Biomedical CEO Named AATB '50 at 50' Honoree

Boca Raton, Fla. – October 06, 2026 -- C5 Biomedical LLC CEO Tim Maye, CTBS, is being honored tonight in San Francisco as one of 50 individuals named to the Association for Advancing Tissue and Biologics' (AATB) one-time "50 at 50" list, marking the organization's 50th anniversary.

Maye's 28-year tissue banking career includes six years chairing AATB's Standards Committee

Maye has held his Certified Tissue Bank Specialist (CTBS) credential since 1999 and spent six years chairing AATB's Standards Committee, the body responsible for the tissue banking standards the industry operates under today. He founded C5 Biomedical in 2021 and remains on the Standards Committee.

Luminous Mind Wins Patent for Non-Hallucinogenic Psychedelic Mushrooms

Boston – October 06, 2026 -- Luminous Mind, Inc. (LMI) has secured U.S. Patent No. 12,697,362, covering technology that produces non-hallucinogenic psychedelic fungi, targeting a functional mushroom market Grand View Research values at $38.2 billion for 2025.

Patent strips psilocybin while preserving secondary metabolites

The patent isolates beneficial compounds found in psilocybin-containing mushrooms -- secondary metabolites and active fungal molecules typically overshadowed by the hallucinogen. By removing psilocybin, LMI says the resulting products retain potential nutraceutical benefits without triggering hallucinations, opening a path to mass-market commercialization that psychedelic-based products cannot access under current regulatory frameworks.